XIAOMING JIA to Risk Assessment
This is a "connection" page, showing publications XIAOMING JIA has written about Risk Assessment.
Connection Strength
0.728
-
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800.
Score: 0.360
-
Optimal Stenting Technique for Lesions at the Ostium of the Left Anterior Descending Artery: A Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv. 2025 Aug; 106(2):926-933.
Score: 0.119
-
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date. Vasc Health Risk Manag. 2020; 16:1-10.
Score: 0.082
-
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019 06 04; 139(23):2642-2653.
Score: 0.078
-
Early-onset atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2025 Jan 27; 32(2):100-112.
Score: 0.029
-
Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes. Diabetes Care. 2020 06; 43(6):1200-1208.
Score: 0.021
-
Estimates of radiation exposure and subsequent risk of malignancy due to cardiac imaging in the emergency department for evaluation of chest pain: a cohort study. Coron Artery Dis. 2019 Dec; 30(8):626-628.
Score: 0.020
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.019